Building Slowly Beats Waiting for Perfect

Last week I deployed across 8 stock positions in a single week. Not huge positions — PBH, META, CDW, PPC, SLVM, MSFT, MFI, NVDA — but I deployed.

Why does this matter? Because three weeks ago, I had 28 stocks. I kept saying “I need to get to 50 for proper diversification.” But I also kept waiting. Waiting for better entries. Waiting for perfect chart setups. Waiting for “the right time.”

The result? I sat at 28-30 stocks for months while my Technology sector was 15% underweight and Healthcare barely existed in my portfolio.

Last week, I stopped waiting. Deployed to 8 positions in five days. By Friday, the portfolio sat at 36 stocks — a 29% increase in diversification. Technology went from catastrophically underweight to just moderately underweight. Healthcare finally has some presence.

Did I catch perfect entries? No. CDW is already down 10%. NVDA down 4.5%. META down 4%. But here’s what else happened: The portfolio is materially more diversified. Sector gaps are closing. And I’m actually making progress toward the 50-stock target instead of just talking about it.

The performance this week? Mixed. 50% of picks beat SPY, 50% lagged. Average return: -2.1%. Not great. But the alternative was sitting at 28 stocks with massive sector concentration risk while waiting for “better opportunities” that might never come.

Perfection is the enemy of progress. I’d rather own 36 quality stocks with imperfect entries than 28 stocks and a pile of excuses.

Week Ending	This Week	YTD Performance
February 15, 2026	SPY +1.2% / Blue +0.8% / Variance -0.4%	Blue +18.1% / SPY +20.3% / Gap -2.2%

Last Week’s Picks: How Did They Perform?

This section tracks ALL positions opened in the last 4 weeks for full transparency.

Ticker	Entry Date	Entry Price	Current Price	Gain %	vs SPY	Weeks Held	Grade
PBH	Feb 9	$66.06	$66.78	+1.1%	-0.1%	1	B
META	Feb 11	$666.70	$639.80	-4.0%	-5.2%	1	C
CDW	Feb 10	$141.36	$126.86	-10.3%	-11.5%	1	D
PPC	Feb 9	$43.06	$43.31	+0.6%	-0.6%	1	B
SLVM	Feb 9	$50.88	$51.37	+1.0%	-0.2%	1	B
MSFT	Feb 9	$411.70	$401.43	-2.5%	-3.7%	1	C
MFI	Feb 10	$27.19	$27.75	+2.1%	+0.9%	1	A
NVDA	Feb 9	$191.53	$183.00	-4.5%	-5.7%	1	C

Grade Key: A = Beat SPY by >2% | B = Beat SPY 0-2% or lagged <1% | C = Lagged 1-3% | D = Lagged 3-5% | F = Lagged >5%

Analysis:

Mixed results for last week’s deployment. CDW was the clear loser, dropping 10.3% shortly after purchase – a reminder that even quality companies can have bad timing. NVDA and META also underperformed despite strong fundamentals.

On the positive side: PBH, PPC, SLVM, and MFI all held up well, with MFI actually beating SPY. The 50% hit rate is acceptable for week 1, though the average -2.1% performance shows the market didn’t cooperate with these entries.

This transparency is exactly why I track performance publicly – showing the losers along with winners keeps me honest about what’s actually working.

Positions Closed This Week

Ticker	Shares Sold	Reason
CNQ.TO	5 shares	Trimmed position – rebalancing Energy sector (still holding 5 shares)

Lessons Learned Last Week

Small Positions Beat No Positions

The NVDA purchase — half a share for $100 — taught me something important. It’s already down 4.5% and underperforming SPY. My first instinct is to feel bad about the timing.

But here’s the thing: I’ve wanted NVDA exposure for months. I missed it at $170, $180, and $190 because I kept waiting for “better.” When I finally bought at $191, it dropped to $183 by Friday.

The lesson isn’t “see, you should have waited longer.” The lesson is: size the position appropriately for your conviction and timing uncertainty.

I didn’t know if $191 was the bottom. So I bought 0.5 shares instead of 5. If it drops to $170, I can add more. If it runs to $220, I at least have some exposure. The worst outcome isn’t buying and being wrong — it’s sitting in cash while quality companies compound without you.

This applies to the broader 50-stock strategy too. I deployed across 8 positions last week. Some are up, some are down. But the portfolio is 13% more diversified than seven days ago, and I’m making systematic progress toward the target allocation.

Takeaway: Imperfect action beats perfect inaction. Every time.

This Week’s Market Context

Economic Calendar (Week of Feb 17-21):

• Monday: Presidents’ Day (markets closed)
• Tuesday: Housing starts data
• Wednesday: FOMC minutes release (2pm ET)
• Thursday: Jobless claims
• Friday: Consumer sentiment

How This Affects My Watchlist:

With markets closed Monday, I’ll execute the ZBRA and FFIV purchases Tuesday. The FOMC minutes Wednesday could create volatility, but since both stocks have confirmed weekly setups, short-term noise doesn’t change the fundamental thesis.

What Would Make Me Pause

I will NOT buy this week if:

• ❌ SPY breaks below 20-week SMA on heavy volume (currently $548, SPY at $561)
• ❌ VIX spikes above 25 (panic mode, wait for stabilization)
• ❌ Wednesday FOMC minutes suggest hawkish pivot (rate hikes back on table)
• ❌ Technology sector selloff >3% before Tuesday open (invalidates entries)

Blue Portfolio Performance Dashboard

Overall Performance

Period	Blue Portfolio	SPY	Variance	Status
This Week	+0.8%	+1.2%	-0.4%	Lagging
Month-to-Date	+3.2%	+4.1%	-0.9%	Lagging
Year-to-Date	+18.1%	+20.3%	-2.2%	Catching up ✅
Since Inception	+18.1%	+20.3%	-2.2%	Narrowing gap

Current Status: Lagging SPY short-term, but the YTD gap has narrowed from -4.2% two weeks ago to -2.2% now. The 50-stock sector-weighted strategy is showing early signs of working.